Palbociclib Impurity A is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Also, it is derived from 3-Fluoro-2-nitropyridine (F597685). Molecular Formula: C24H29N7O2 Molecular Weight: 447.53 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
447.53
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten